New targeted pill aims to shrink tough tumors with specific genetic flaw
Disease control
Recruiting now
This study is testing an oral drug called plixorafenib (FORE8394) for people with advanced solid tumors or brain tumors that have specific changes in a gene called BRAF. The main goal is to see if the drug can shrink tumors and is safe for patients, including adults and children …
Phase: PHASE2 • Sponsor: Fore Biotherapeutics • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC